tiprankstipranks
Trending News
More News >
CNO Financial Group (CNO)
:CNO
Advertisement

CNO Financial (CNO) AI Stock Analysis

Compare
114 Followers

Top Page

CNO

CNO Financial

(NYSE:CNO)

Select Model
Select Model
Select Model
Outperform 72 (OpenAI - 4o)
Rating:72Outperform
Price Target:
$44.00
▲(11.39% Upside)
CNO Financial's overall score is driven by strong earnings call performance and stable financials, despite challenges in profit margins and certain business segments. The technical analysis suggests a stable long-term trend, while the valuation remains reasonable. The company's strategic initiatives and growth in key areas are significant positives.
Positive Factors
Revenue Growth
The significant increase in new annualized premiums indicates robust demand for CNO's products, suggesting sustained revenue growth and market expansion potential.
Strategic Initiatives
The Bermuda treaty is expected to improve operating ROE by 50 basis points through 2027, enhancing long-term profitability and financial stability.
Operational Efficiency
The increase in operating earnings per share reflects improved operational efficiency, which supports sustainable profit growth and shareholder value.
Negative Factors
Profit Margin Decline
The decline in profit margins suggests increased costs or pricing pressures, which could impact profitability if not addressed.
Impairment Charges
Significant impairment charges can affect financial results and indicate challenges in asset valuation or business strategy execution.
Exit from Worksite Fee Services
Exiting this business segment may reduce revenue streams and highlights challenges in maintaining competitive advantage in certain areas.

CNO Financial (CNO) vs. SPDR S&P 500 ETF (SPY)

CNO Financial Business Overview & Revenue Model

Company DescriptionCNO Financial Group, Inc. is a financial services holding company specializing in the insurance and financial services sectors. The company primarily serves middle-income working Americans, providing a range of products including life insurance, health insurance, annuities, and retirement solutions. CNO operates through several brands, including Colonial Penn, Bankers Life, and Washington National, catering to the unique financial needs of its customers across various stages of life.
How the Company Makes MoneyCNO Financial generates revenue through multiple streams, primarily through the sale of insurance products and services. The company's key revenue sources include premiums collected from life and health insurance policies, which provide a steady income stream. Additionally, CNO earns revenue from investment income generated by managing the premiums it receives before claims are paid out. Annuity sales also contribute to its revenue, as the company offers various annuity products that yield returns over time. Partnerships with agents and brokers enhance distribution, enabling CNO to reach a broader market and increase sales. Furthermore, CNO's focus on middle-income Americans positions it uniquely in a niche market, allowing for sustained growth and profitability.

CNO Financial Earnings Call Summary

Earnings Call Date:Nov 03, 2025
(Q3-2025)
|
% Change Since: |
Next Earnings Date:Feb 10, 2026
Earnings Call Sentiment Positive
CNO Financial Group delivered a strong quarter with significant growth in new annualized premiums and operating earnings per share. The Consumer and Worksite divisions achieved record sales growth. However, challenges included the exit from the Worksite fee services business with associated impairment charges and a decline in Medicare Advantage sales.
Q3-2025 Updates
Positive Updates
Strong Quarterly Performance
CNO Financial Group delivered a strong quarter with record total new annualized premiums of $125 million, up 26%. Operating earnings per diluted share were $1.29, up 16%.
Record Sales Growth in Consumer Division
The Consumer Division delivered its 12th consecutive quarter of sustained growth. Total Life insurance sales were up 33%, and record direct-to-consumer life insurance sales increased by 56%.
Worksite Division Insurance Sales
Worksite Life and Health NAP was up 20%, marking the seventh consecutive quarter of record NAP growth. Strategic growth initiatives contributed significantly, with a 42% increase in NAP growth.
Continued Growth in Annuities and Advisory
Annuity collected premiums were up 2%, marking the ninth consecutive quarter of growth. Client assets in brokerage and advisory were up 28%, surpassing $5 billion.
New Bermuda Treaty
CNO Financial executed a second Bermuda treaty, ceding approximately $1.8 billion of Supplemental Health U.S. statutory reserves, contributing to an expected 50 basis point improvement in operating ROE through 2027.
Negative Updates
Exit from Worksite Fee Services Business
CNO decided to exit the Worksite fee services business, which contributed a pretax annual loss of approximately $20 million. This decision followed years of underperformance and increased competition.
Impairment Charges
CNO recorded a $96.7 million impairment in non-operating income on the goodwill and intangibles associated with the acquisitions of Web Benefit Design and DirectPath.
Challenges in Medicare Advantage Sales
Medicare Advantage policies sold were down 24%, reflecting a shift in consumer preferences from Medicare Advantage to Medicare Supplement plans.
Company Guidance
During the CNO Financial Group's Third Quarter 2025 Earnings Call, several key metrics and strategic moves were highlighted. The company reported record total new annualized premiums of $125 million, marking a 26% increase and sustaining double-digit insurance sales growth across both divisions. Operating earnings per diluted share rose by 16% to $1.29. CNO also returned $76 million to shareholders in the quarter and $310 million year-to-date, while the book value per diluted share, excluding AOCI, was $38.10, up 6%. The company announced a second Bermuda treaty and changes to its Worksite Division's fee services business, aiming for a 50 basis point improvement in operating ROE through 2027. The growth scorecard metrics were predominantly positive, with particular strength in the Consumer Division, which saw Life and Health New Annualized Premiums (NAP) rise by 27% and direct-to-consumer life insurance sales increase by 56%. Meanwhile, the Worksite Division delivered a seventh consecutive quarter of record NAP growth at 20%, with highlights including significant growth in life, hospital indemnity, critical illness, and accident insurance. Additionally, CNO's annuity collected premiums grew 2%, maintaining a nine-quarter growth streak, with client assets in brokerage and advisory soaring 28%, surpassing $5 billion.

CNO Financial Financial Statement Overview

Summary
CNO Financial demonstrates moderate financial health with stable revenue growth and cash flow generation. However, profitability margins have declined, and high leverage poses potential risks. The company should focus on improving operational efficiency and managing debt levels to enhance financial stability and shareholder value.
Income Statement
75
Positive
CNO Financial shows moderate revenue growth with a TTM growth rate of 1.98%. The gross profit margin is stable at 38.31% in TTM, but has decreased from previous years. Net profit margin is relatively low at 6.41% in TTM, indicating room for improvement in profitability. EBIT and EBITDA margins have also declined, suggesting potential challenges in operational efficiency.
Balance Sheet
68
Positive
The debt-to-equity ratio is high at 1.64 in TTM, indicating significant leverage which could pose risks if not managed carefully. Return on equity has decreased to 10.97% in TTM, reflecting reduced profitability for shareholders. The equity ratio is not provided, but the high leverage suggests a need for cautious financial management.
Cash Flow
70
Positive
CNO Financial's free cash flow growth is positive at 5.17% in TTM, showing improvement in cash generation. The operating cash flow to net income ratio is strong at 45.45, indicating good cash conversion. The free cash flow to net income ratio remains stable at 1.0, suggesting consistent cash flow relative to earnings.
BreakdownTTMDec 2024Dec 2023Dec 2022Dec 2021Dec 2020
Income Statement
Total Revenue4.44B4.45B4.15B3.58B4.12B3.82B
Gross Profit1.79B1.70B1.53B1.79B1.70B1.28B
EBITDA934.90M1.07B862.80M1.20B1.07B757.00M
Net Income294.70M404.00M276.50M630.60M570.30M301.80M
Balance Sheet
Total Assets38.30B37.85B35.03B33.13B36.20B35.34B
Cash, Cash Equivalents and Short-Term Investments8.60B9.45B22.28B20.42B24.91B23.44B
Total Debt4.05B4.52B4.15B3.88B4.00B3.93B
Total Liabilities35.69B35.35B32.81B31.36B30.94B29.86B
Stockholders Equity2.61B2.50B2.22B1.77B5.26B5.48B
Cash Flow
Free Cash Flow671.00M627.70M582.90M495.40M598.30M735.50M
Operating Cash Flow671.00M627.70M582.90M495.40M598.30M735.50M
Investing Cash Flow-917.70M-1.49B-872.30M-1.78B-1.53B-608.40M
Financing Cash Flow243.00M1.97B533.50M1.20B667.60M210.10M

CNO Financial Technical Analysis

Technical Analysis Sentiment
Positive
Last Price39.50
Price Trends
50DMA
40.04
Positive
100DMA
38.96
Positive
200DMA
38.79
Positive
Market Momentum
MACD
0.24
Negative
RSI
54.74
Neutral
STOCH
66.27
Neutral
Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For CNO, the sentiment is Positive. The current price of 39.5 is below the 20-day moving average (MA) of 40.65, below the 50-day MA of 40.04, and above the 200-day MA of 38.79, indicating a bullish trend. The MACD of 0.24 indicates Negative momentum. The RSI at 54.74 is Neutral, neither overbought nor oversold. The STOCH value of 66.27 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for CNO.

CNO Financial Risk Analysis

CNO Financial disclosed 33 risk factors in its most recent earnings report. CNO Financial reported the most risks in the "Finance & Corporate" category.
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy
Latest Risks Added 0 New Risks

CNO Financial Peers Comparison

Overall Rating
UnderperformOutperform
Sector (68)
Financial Indicators
Name
Overall Rating
Market Cap
P/E Ratio
ROE
Dividend Yield
Revenue Growth
EPS Growth
74
Outperform
$3.75B4.4716.27%27.71%
74
Outperform
$4.35B9.6510.12%2.78%-4.58%
72
Outperform
$3.93B14.4211.12%1.60%-1.61%15.79%
70
Outperform
$7.81B3.6921.66%4.39%35.76%636.97%
69
Neutral
$6.66B13.565.50%3.36%24.94%
68
Neutral
$18.00B11.429.92%3.81%9.73%1.22%
60
Neutral
$3.50B19.282.86%1.41%150.35%
* Financial Sector Average
Performance Comparison
Ticker
Company Name
Price
Change
% Change
CNO
CNO Financial
40.93
2.23
5.76%
GNW
Genworth Financial
8.68
0.92
11.86%
LNC
Lincoln National
41.14
7.72
23.10%
BHF
Brighthouse Financial
65.55
13.17
25.14%
JXN
Jackson Financial Incorporation
98.01
1.06
1.09%
FG
F&G Annuities & Life Inc
32.31
-15.32
-32.16%

CNO Financial Corporate Events

CNO Financial Group Reports Strong Q3 2025 Results
Nov 5, 2025

CNO Financial Group, Inc. is a company that provides life and health insurance, annuities, financial services, and workforce benefits solutions, primarily serving middle-income America through its family of brands. In its third quarter of 2025, CNO Financial Group reported a significant increase in net income, reaching $23.1 million, up from $9.3 million in the same quarter of the previous year. The company also saw a rise in net operating income, which excludes non-economic accounting impacts, to $127.2 million from $119.2 million. This growth was driven by strong sales in both its Consumer and Worksite Divisions, with record Direct-to-Consumer and Worksite insurance sales.

CNO Financial Group Reports Strong Growth Amid Strategic Shifts
Nov 5, 2025

CNO Financial Group’s recent earnings call painted a picture of robust growth and strategic adjustments. The overall sentiment was positive, with significant achievements in new annualized premiums and operating earnings per share. However, the company faced challenges, including the exit from the Worksite fee services business and a decline in Medicare Advantage sales.

Business Operations and Strategy
CNO Financial Highlights Strategic Focus in New Briefing
Positive
Sep 10, 2025

On September 10, 2025, CNO Financial Group issued a Consumer Division Briefing presentation, highlighting its strategic focus on middle-income households and its commitment to growth through multiple distribution channels. The briefing emphasized CNO’s differentiated ‘health and wealth’ approach, its strong market positioning, and consistent growth, with a notable increase in Medicare Advantage sales and a growing distribution force. The company aims to continue building enduring value for stakeholders and addressing the needs of an underserved market.

The most recent analyst rating on (CNO) stock is a Buy with a $42.00 price target. To see the full list of analyst forecasts on CNO Financial stock, see the CNO Stock Forecast page.

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.Date of analysis: Nov 18, 2025